INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
Watch INmune Bio explain itInmune Bio (NASDAQ:INMB) Q3 2025 Earnings Call · Replay · Oct 30, 2025 · From 16:20 · Financial Results and Guidance
INmune Bio's next earnings callInmune Bio (NASDAQ:INMB) Q3 2026 Earnings Call · Nov 5, 2026 at 4:30 PM ESTRegister
The original release is unavailable here.
Story so far
Earlier from INmune Bio
- INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
- INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
- INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
- INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult
- INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes
Later from INmune Bio
- INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
- INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients
- Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
- INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives
- INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB
Follow INmune Bio into a list and get an email when it puts out news.
Follow INmune Bio